| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.146 | 22.322 | - | 6.765 | 0 | 0 | 0 | 0 | 0 | 18.549 |
| Total Income - EUR | 19.146 | 22.323 | - | 6.818 | 0 | 0 | 0 | 0 | 0 | 18.549 |
| Total Expenses - EUR | 12.579 | 15.517 | - | 4.981 | 451 | 322 | 315 | 66 | 530 | 2.945 |
| Gross Profit/Loss - EUR | 6.567 | 6.806 | - | 1.836 | -451 | -322 | -315 | -66 | -530 | 15.604 |
| Net Profit/Loss - EUR | 6.010 | 6.584 | - | 1.725 | -451 | -322 | -315 | -66 | -530 | 14.474 |
| Employees | 1 | 2 | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Stănescu-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.054 | 2.454 | - | 1.199 | 724 | 389 | 65 | 0 | 0 | 0 |
| Current Assets | 13.529 | 9.895 | - | 3.325 | 2.675 | 3.199 | 3.128 | 3.137 | 2.711 | 11.147 |
| Inventories | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 675 |
| Receivables | 842 | 796 | - | 2.866 | 2.659 | 2.757 | 2.696 | 2.704 | 2.696 | 2.681 |
| Cash | 12.688 | 9.099 | - | 459 | 16 | 442 | 432 | 433 | 15 | 7.792 |
| Shareholders Funds | 12.182 | 6.638 | - | -7.727 | -8.028 | -8.198 | -8.331 | -8.422 | -8.927 | 5.597 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.594 | 5.902 | - | 12.435 | 11.609 | 11.963 | 11.697 | 11.734 | 11.811 | 5.723 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Stănescu-Med Srl